EsoCap Announces Publication “Development of a Hot- Melt Extrusion-Based Spinning Process to Produce Pharmaceutical Fibers and Yarns”

EsoCap has announced that scientists from the University of Greifswald have published important data regarding a hot-melt extrusion-based spinning process to produce pharmaceutical fibers and yarns. This spinning process is…

Continue Reading EsoCap Announces Publication “Development of a Hot- Melt Extrusion-Based Spinning Process to Produce Pharmaceutical Fibers and Yarns”

EsoCap supports first European EoE Day of the European Society of Eosinophilic Oesophagitis on May 22, 2022

Patients with eosinophilic esophagitis (EoE) suffer from severe symptoms including swallowing disorders, food impaction, vomiting, and heartburn EsoCap is currently conducting a randomized, placebo-controlled, double-blind Phase II trial to treat…

Continue Reading EsoCap supports first European EoE Day of the European Society of Eosinophilic Oesophagitis on May 22, 2022

EsoCap announces issue of a patent in Mexico for its smart application technology in the upper gastrointestinal tract

EsoCap AG announced today that the Mexican Patent and Trademark Office has issued a patent under number 383626, based on Patent Application No. MX/a/2017/007566. The patent is directed at the…

Continue Reading EsoCap announces issue of a patent in Mexico for its smart application technology in the upper gastrointestinal tract

EsoCap featured in Fierce Pharma

EsoCap AG has been featured in Fierce Pharma Online. “We are extremely pleased that Fierce Pharma Online reviewed EsoCap’s unique and innovative topical drug delivery system to the esophagus and…

Continue Reading EsoCap featured in Fierce Pharma

EsoCap holds a multidisciplinary scientific advisory board meeting with thirteen international experts

EsoCap AG organized a multidisciplinary scientific advisory board meeting in Zurich with thirteen international experts on June 27, 2019. As an introduction, Prof. Werner Weitschies, Center for Drug Absorption and…

Continue Reading EsoCap holds a multidisciplinary scientific advisory board meeting with thirteen international experts

EsoCap announces authorisation of capital increase by extraordinary general assembly and successful closing of its private placement offering

EsoCap AG announced that a capital increase has been authorized by the Extraordinary General Assembly, held on April 11, 2019, followed by successful completion of a private placement financing. The…

Continue Reading EsoCap announces authorisation of capital increase by extraordinary general assembly and successful closing of its private placement offering

EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019

EsoCap AG is one of just a handful of companies in the area of biotech and medtech selected to present at the Bio-Europe conference start-up spotlight on March 26th, 2019 in Vienna.

Continue Reading EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019